Papaverine hydrochloride tablets for children 0,01 g

  • Home
  • Medicine
  • Papaverine hydrochloride tablets for children 0,01 g

Overdose

Symptoms : during an overdose, pronounced drowsiness, dizziness, collaptoid state occurs.

Treatment: first aid - washing the stomach, taking activated carbon. Symptomatic therapy.

Contraindications

AV blockade.

Pharmaceutical form

Pills of white or white with a weak yellow touch of color.

Undesirable effects

AV blockade, ventricular extrasystolia, hypotension, constipation, drowsiness.

Therapeutic indications

Spasms of the vessels of the brain, angina pectoris, endarteritis, cholecystitis, pylorospasm, spastic colitis, renal colic.

Pharmacotherapeutic group

  • Vasodilators
  • Spasmolithics are myotropic

Special precautions for storage

In a place protected from the light.

Keep out of the reach of children.

The shelf life of the drug Papaverin hydrochloride tablets for children is 0.01 g

tablets for children 10 mg - 3 years.

injection solution 20 mg / ml - 2 years.

injection solution 20 mg / ml - 2 years.

Do not apply after the expiration date indicated on the package.

Nature and contents of container

1 ampoule with 2 ml of injection solution contains 0.04 g of hydrochloride papaverin; in a box of 10 pcs.

1 tablet for children - 0.01 g; in a contour unlabeled package of 6 or 10 pcs.

Nosological classification (ICD-10)

  • I84 Hemorrhoids
  • K25 stomach ulcer
  • K26 Twin bowel ulcer
  • R11 Nausea and vomiting
  • Z100 * CLASS XXII Surgical practice

Qualitative and quantitative composition

Papaverine

Dosage (Posology) and method of administration

Inside, with bowel spasms, gall bladder and other conditions associated with spasm of smooth muscles: children 6 - 2 years old - 1 / 4–1 / 2 tablets., 3-4 years old - 1 / 2-1 table.5–6 years old - 1 table.7–9 years old - 1.5 tablets.10-14 years old - 1.5-2 tablets.; adults - 4 tablets. 3-4 times a day.

P / c, c / m, c / c (very slow) - 1–2 ml of 1–2% solution.

ATC - Anatomical and therapeutic chemical classification

A03AD01 Papaverin